首页> Journal of Alzheimer's disease : JAD> Biomarkers and Risk Assessment of Alzheimer's Disease in Low- and Middle-Income Countries.

Biomarkers and Risk Assessment of Alzheimer's Disease in Low- and Middle-Income Countries.

导出原文传递

翻译打印收藏纠错

第一作者： Boluwatife Adeleye,Adewale

第一单位： Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria.;Neuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training (IAMRAT), College of Medicine, University of Ibadan, Ibadan, Nigeria.

作者： Boluwatife Adeleye,Adewale ^[1] ; Motunrayo Mojoyin,Coker ^[2] ; Adesola,Ogunniyi ^[3] ; Rajesh N,Kalaria ^[4] ; Rufus Olusola,Akinyemi ^[5]

作者单位： Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria.;Neuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training (IAMRAT), College of Medicine, University of Ibadan, Ibadan, Nigeria. ^[1] Neuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training (IAMRAT), College of Medicine, University of Ibadan, Ibadan, Nigeria. ^[2] Neuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training (IAMRAT), College of Medicine, University of Ibadan, Ibadan, Nigeria.;Department of Neurology, University College Hospital, Ibadan, Nigeria. ^[3] Neuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training (IAMRAT), College of Medicine, University of Ibadan, Ibadan, Nigeria.;Translational and Clinical Research Institute, Newcastle University, United Kingdom. ^[4] Neuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training (IAMRAT), College of Medicine, University of Ibadan, Ibadan, Nigeria.;Department of Neurology, University College Hospital, Ibadan, Nigeria.;Centre for Genomic and Precision Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.;Translational and Clinical Research Institute, Newcastle University, United Kingdom. ^[5]

关键词 Alzheimer’s disease artificial intelligence biomarkers blood cerebrospinal fluid low- and middle-income countries neuroimaging risk